Arteriosclerosis and Thrombosis, Vol 14, 1021-1031, Copyright © 1994 by American Heart Association
ARTICLES |
JA Rimarachin, JA Jacobson, P Szabo, J Maclouf, C Creminon and BB Weksler
Division of Hematology-Oncology, Cornell University Medical College, New York, NY 10021.
Activation of the gene for inducible cyclooxygenase (cyclooxygenase-2 [Cox-2], prostaglandin endoperoxide synthase) is an early response to injury in vascular smooth muscle cells. We used in vitro and in vivo models to demonstrate that activation of quiescent smooth muscle cells by mitogens leads to a rapid, short-term rise in mRNA for Cox-2, followed by synthesis of new Cox-2 enzyme protein and a marked increase in prostaglandin production that depends on new enzyme synthesis. Moreover, the Cox-2 mRNA response observed in smooth muscle cells differs in both time and degree, depending on the particular mitogenic stimulus. Serum, platelet-derived growth factor, epidermal growth factor, and thrombin are strong inducers of Cox-2 mRNA, whereas acidic and basic fibroblast growth factors and interleukin-1 alpha are weak inducers. In contrast to the transient activation of Cox-2 in vitro after introduction of a mitogenic stimulus, the Cox-2 response after in vivo vascular injury extends over many days and may represent protracted cellular activation. During induction of Cox-2 message and protein, expression of constitutive cyclooxygenase (Cox-1) remains unchanged, however. These data suggest a pathophysiological role for Cox-2 in the early modulation of vascular responses to injury.
This article has been cited by other articles:
![]() |
R. Pape, B. H. Rauch, A. C. Rosenkranz, G. Kaber, and K. Schror Transcriptional Inhibition of Protease-Activated Receptor-1 Expression by Prostacyclin in Human Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 534 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Clement, M. Gueguen, M. Glorian, R. Blaise, M. Andreani, C. Brou, P. Bausero, and I. Limon Notch3 and IL-1beta exert opposing effects on a vascular smooth muscle cell inflammatory pathway in which NF-{kappa}B drives crosstalk J. Cell Sci., October 1, 2007; 120(19): 3352 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van den Boom, M. Sarbia, K. von Wnuck Lipinski, P. Mann, J. Meyer-Kirchrath, B.H. Rauch, K. Grabitz, B. Levkau, K. Schror, and J.W. Fischer Differential Regulation of Hyaluronic Acid Synthase Isoforms in Human Saphenous Vein Smooth Muscle Cells: Possible Implications for Vein Graft Stenosis Circ. Res., January 6, 2006; 98(1): 36 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Deeb, H. Shen, C. Gamss, T. Gavrilova, B. D. Summers, R. Kraemer, G. Hao, S. S. Gross, M. Laine, N. Maeda, et al. Inducible Nitric Oxide Synthase Mediates Prostaglandin H2 Synthase Nitration and Suppresses Eicosanoid Production Am. J. Pathol., January 1, 2006; 168(1): 349 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, W. Su, S. Allen, H. Pang, A. Daugherty, E. Smart, and M. C. Gong COX-2 Up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice Cardiovasc Res, September 1, 2005; 67(4): 723 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zaric and C. Ruegg Integrin-mediated Adhesion and Soluble Ligand Binding Stabilize COX-2 Protein Levels in Endothelial Cells by Inducing Expression and Preventing Degradation J. Biol. Chem., January 14, 2005; 280(2): 1077 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Upmacis, R. S. Deeb, M. J. Resnick, R. Lindenbaum, C. Gamss, D. Mittar, and D. P. Hajjar Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1271 - C1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bishop-Bailey, T. Hla, and T. D. Warner Intimal Smooth Muscle Cells as a Target for Peroxisome Proliferator-Activated Receptor-{gamma} Ligand Therapy Circ. Res., August 9, 2002; 91(3): 210 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katsuyama, C. Fan, and C. Yabe-Nishimura NADPH Oxidase Is Involved in Prostaglandin F2alpha -induced Hypertrophy of Vascular Smooth Muscle Cells. INDUCTION OF NOX1 BY PGF2alpha J. Biol. Chem., April 12, 2002; 277(16): 13438 - 13442. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fritsche, S. J. Baek, L. M. King, D. C. Zeldin, T. E. Eling, and D. A. Bell Functional Characterization of Cyclooxygenase-2 Polymorphisms J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 468 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, P. Bulic, Y. Lin, A. J. Dannenberg, and D. S. Pasco Development and Use of a Gene Promoter-Based Screen to Identify Novel Inhibitors of Cyclooxygenase-2 Transcription J Biomol Screen, April 1, 2001; 6(2): 101 - 110. [Abstract] [PDF] |
||||
![]() |
D. Praticò, C. Tillmann, Z.-B. Zhang, H. Li, and G. A. FitzGerald Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice PNAS, March 1, 2001; (2001) 61607398. [Abstract] [Full Text] |
||||
![]() |
D. Wu, M. G. Hayek, and S. N. Meydani Vitamin E and Macrophage Cyclooxygenase Regulation in the Aged J. Nutr., February 1, 2001; 131(2): 382S - 388. [Abstract] [Full Text] |
||||
![]() |
M. Mietus-Snyder, M. S. Gowri, and R. E. Pitas Class A Scavenger Receptor Up-regulation in Smooth Muscle Cells by Oxidized Low Density Lipoprotein. ENHANCEMENT BY CALCIUM FLUX AND CONCURRENT CYCLOOXYGENASE-2 UP-REGULATION J. Biol. Chem., June 2, 2000; 275(23): 17661 - 17670. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Young, K. Mahboubi, A. Haider, I. Li, and N. R. Ferreri Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-{alpha}- and Angiotensin II-Mediated Proliferation of Vascular Smooth Muscle Cells Circ. Res., April 28, 2000; 86(8): 906 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-C. Garcia-Cohen, J. Marin, L. D. Diez-Picazo, A. B. Baena, M. Salaices, and M. A. Rodriguez-Martinez Oxidative Stress Induced by tert-Butyl Hydroperoxide Causes Vasoconstriction in the Aorta from Hypertensive and Aged Rats: Role of Cyclooxygenase-2 Isoform J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 75 - 81. [Abstract] [Full Text] |
||||
![]() |
Z. Yan, K. Subbaramaiah, T. Camilli, F. Zhang, T. Tanabe, T. A. McCaffrey, A. J. Dannenberg, and B. B. Weksler Benzo[a]pyrene Induces the Transcription of Cyclooxygenase-2 in Vascular Smooth Muscle Cells. EVIDENCE FOR THE INVOLVEMENT OF EXTRACELLULAR SIGNAL-REGULATED KINASE AND NF-kappa B J. Biol. Chem., February 18, 2000; 275(7): 4949 - 4955. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, N. Ma, M. J. Szabolcs, J. Zhong, E. Athan, R. R. Sciacca, R. E. Michler, G. D. Anderson, J. F. Wiese, K. M. Leahy, et al. Upregulation of COX-2 During Cardiac Allograft Rejection Circulation, February 1, 2000; 101(4): 430 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohnaka, K. Numaguchi, T. Yamakawa, and T. Inagami Induction of Cyclooxygenase-2 by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells Hypertension, January 1, 2000; 35(1): 68 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bernard, R. Merval, M. Lebret, P. Delerive, I. Dusanter-Fourt, S. Lehoux, C. Creminon, B. Staels, J. Maclouf, and A. Tedgui Oncostatin M Induces Interleukin-6 and Cyclooxygenase-2 Expression in Human Vascular Smooth Muscle Cells : Synergy With Interleukin-1{beta} Circ. Res., December 3, 1999; 85(12): 1124 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Wohlfeil and W. B. Campbell 25-Hydroxycholesterol Increases Eicosanoids and Alters Morphology in Cultured Pulmonary Artery Smooth Muscle and Endothelial Cells Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2901 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto Increase in Prostaglandin E2 Production by Interleukin-1{beta} in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease Circ. Res., November 12, 1999; 85(10): 912 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schonbeck, G. K. Sukhova, P. Graber, S. Coulter, and P. Libby Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions Am. J. Pathol., October 1, 1999; 155(4): 1281 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Subbaramaiah, N. Altorki, W. J. Chung, J. R. Mestre, A. Sampat, and A. J. Dannenberg Inhibition of Cyclooxygenase-2 Gene Expression by p53 J. Biol. Chem., April 16, 1999; 274(16): 10911 - 10915. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. R. Baker, R. J. C. Hall, T. J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M. H. Yacoub, and J. M. Polak Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particularly in Macrophages Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 646 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. McAdam, F. Catella-Lawson, I. A. Mardini, S. Kapoor, J. A. Lawson, and G. A. FitzGerald Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2 PNAS, January 5, 1999; 96(1): 272 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Binko, S. Meachem, and H. Majewski Endothelium removal induces iNOS in rat aorta in organ culture, leading to tissue damage Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E125 - E134. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. A. Moore, L. L. Stoll, G. Rich, T. L. Kaduce, N. L. Weintraub, and A. A. Spector 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2113 - H2121. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Brian Jr, S. A. Moore, F. M. Faraci, and H. A. Kontos Expression and Vascular Effects of Cyclooxygenase-2 in Brain • Editorial Comment Stroke, December 1, 1998; 29(12): 2600 - 2606. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cullen, L. Kelly, S. O. Connor, and D. J. Fitzgerald Selective Cyclooxygenase-2 Inhibition by Nimesulide in Man J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 578 - 582. [Abstract] [Full Text] |
||||
![]() |
D. Bishop-Bailey, J. R. Pepper, S. W. Larkin, and J. A. Mitchell Differential Induction of Cyclooxygenase-2 in Human Arterial and Venous Smooth Muscle : Role of Endogenous Prostanoids Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ermert, M. Ermert, A. Althoff, M. Merkle, F. Grimminger, and W. Seeger Vasoregulatory Prostanoid Generation Proceeds Via Cyclooxygenase-2 in Noninflamed Rat Lungs J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1309 - 1314. [Abstract] [Full Text] |
||||
![]() |
G. Luvara, M. E. Pueyo, M. Philippe, C. Mandet, F. Savoie, D. Henrion, and J.-B. Michel Chronic Blockade of NO Synthase Activity Induces a Proinflammatory Phenotype in the Arterial Wall : Prevention by Angiotensin II Antagonism Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1408 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Osuka, Y. Suzuki, Y. Watanabe, M. Takayasu, J. Yoshida, and D. W. Busija Inducible Cyclooxygenase Expression in Canine Basilar Artery After Experimental Subarachnoid Hemorrhage • Editorial Comment Stroke, June 1, 1998; 29(6): 1219 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vinals, J. Martinez-Gonzalez, J. J. Badimon, and L. Badimon HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2) Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3481 - 3488. [Abstract] [Full Text] |
||||
![]() |
J. A. Williams and E. Shacter Regulation of Macrophage Cytokine Production by Prostaglandin E2. DISTINCT ROLES OF CYCLOOXYGENASE-1 AND -2 J. Biol. Chem., October 10, 1997; 272(41): 25693 - 25699. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bishop-Bailey, J. R. Pepper, E.-B. Haddad, R. Newton, S. W. Larkin, and J. A. Mitchell Induction of Cyclooxygenase-2 in Human Saphenous Vein and Internal Mammary Artery Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1644 - 1648. [Abstract] [Full Text] |
||||
![]() |
M. Camacho, N. Godessart, R. Antón, M. Garca, and L. Vila Interleukin-1 Enhances the Ability of Cultured Human Umbilical Vein Endothelial Cells to Oxidize Linoleic Acid J. Biol. Chem., July 21, 1995; 270(29): 17279 - 17286. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pratico, C. Tillmann, Z.-B. Zhang, H. Li, and G. A. FitzGerald Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice PNAS, March 13, 2001; 98(6): 3358 - 3363. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |